SCID-X1: lentiviral Gene Therapy plus Busulfan

被引：0
|
作者：
Krome, Susanne
机构：
来源：
TRANSFUSIONSMEDIZIN | 2019年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [21] Successful gene therapy of severe combined immunodeficiency (SCID-X1)
    Fischer, A
    Hacein-Bey, S
    Le Deist, F
    de Saint-Basile, G
    Hue, C
    Gross, F
    Davies, G
    Wulfraat, N
    Bousso, P
    Cavazzana-calvo, M
    FASEB JOURNAL, 2000, 14 (06): : A931 - A931
  • [22] Gene Therapy of SCID-X1: A 10-Year Survey
    Fischer, A.
    Hacein-Bey-Abina, S.
    Wang, G.
    Bushman, R.
    Cavazzana-Calvo, M.
    HUMAN GENE THERAPY, 2009, 20 (06) : 661 - 661
  • [23] Lentiviral vector integration site analysis in a preclinical study of ex-vivo gene therapy for SCID-X1
    Poletti, V.
    Corre, G.
    Charrier, S.
    Zhang, F.
    Buckland, K.
    Rothe, M.
    Schambach, A.
    Gaspar, B. H.
    Thrasher, A.
    Mavilio, F.
    HUMAN GENE THERAPY, 2016, 27 (11) : A111 - A111
  • [24] Self-inactivating retroviral vectors for gene therapy of SCID-X1
    Thornhill, S., I
    Grassman, E.
    Ulaganathan, M.
    Waddington, S. N.
    Howe, S. J.
    Van der Loo, H.
    Schambach, A.
    Kinnon, C.
    Baum, C.
    Williams, D.
    Thrasher, A. J.
    HUMAN GENE THERAPY, 2008, 19 (04) : 401 - 401
  • [25] Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection
    Throm, Robert E.
    Ouma, Annastasia A.
    Zhou, Sheng
    Chandrasekaran, Anantharaman
    Lockey, Timothy
    Greene, Michael
    De Ravin, Suk See
    Moayeri, Morvarid
    Malech, Harry L.
    Sorrentino, Brian P.
    Gray, John T.
    BLOOD, 2009, 113 (21) : 5104 - 5110
  • [26] In vivo gene therapy for SCID-X1: A novel and accessible approach with no conditioning
    Humbert, O.
    Chan, F.
    Torgerson, T. R.
    Hubbard, N.
    Humphrys, D.
    Adair, J. E.
    Trobridge, G. D.
    Scharenberg, A. M.
    Felsburg, P. J.
    Rawlings, D. J.
    Kiem, H. P.
    HUMAN GENE THERAPY, 2017, 28 (12) : A46 - A46
  • [27] Characterization of retrovirus integration sites in the SCID-X1 gene therapy clinical trial
    Hu, JQ
    Schmidt, M
    Hacein-Bey-Abina, S
    Fischer, A
    Wissler, M
    Prinz, C
    Glimm, H
    Le Deist, F
    Garrigue, A
    Wulffraat, N
    Andre-Schmutz, I
    Cavazzana-Calvo, M
    von Kalle, C
    BLOOD, 2003, 102 (11) : 200A - 200A
  • [28] Polyclonal ex vivo transduction in successful SCID-X1 gene therapy.
    Schmidt, M
    Cavazzana-Calvo, M
    Hacein-Bey, S
    LeDeist, F
    Lemke, N
    Wissler, M
    Fischer, A
    von Kalle, C
    BLOOD, 2001, 98 (11) : 696A - 696A
  • [29] Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1)
    Poletti, Valentina
    Charrier, Sabine
    Corre, Guillaume
    Martin, Samia
    Gjata, Bernard
    Vignaud, Alban
    Zhang, Fang
    Buckland, Karen
    Andre-Schmutz, Isabelle
    Rothe, Michael
    Schambach, Axel
    Pai, Sung-Yun
    Williams, David A.
    Gaspar, H. Bobby
    Cavazzana, Marina
    Thrasher, Adrian J.
    Mavilio, Fulvio
    MOLECULAR THERAPY, 2017, 25 (05) : 304 - 304
  • [30] Correction of Murine SCID-X1 by Lentiviral Gene Therapy Using a Codon-optimized IL2RG Gene and Minimal Pretransplant Conditioning
    Huston, Marshall W.
    van Til, Niek P.
    Visser, Trudi P.
    Arshad, Shazia
    Brugman, Martijn H.
    Cattoglio, Claudia
    Nowrouzi, Ali
    Li, Yuedan
    Schambach, Axel
    Schmidt, Manfred
    Baum, Christopher
    von Kalle, Christof
    Mavilio, Fulvio
    Zhang, Fang
    Blundell, Mike P.
    Thrasher, Adrian J.
    Verstegen, Monique M. A.
    Wagemaker, Gerard
    MOLECULAR THERAPY, 2011, 19 (10) : 1867 - 1877
12345